Dates

Thursday,

Veranstaltung

Veranstalter, Ort

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate Trial

Judith Trotman, Christian Buske, Alessandra Tedeschi, Jeffrey V Matous, David MacDonald, Constantine S Tam, Olivier Tournilhac, Shuo Ma, Steven P Treon, Albert Oriol, Jerry Ping, Eva M Briso, Israel Arango-Hisijara, Meletios A Dimopoulos

Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström's Macroglobulinemia

Lisa Marie Kaiser, Mirja Harms, Daniel Sauter, Vijay P S Rawat, Mirco Glitscher, Eberhard Hildt, Daniel Tews, Zachary Hunter, Jan Münch, Christian Buske

Imprint

Impressum

Prof. Dr. C. Buske
Comprehensive Cancer Center Ulm
Institute of Experimental Cancer Research
University Hospital Ulm
James-Franck-Ring

89081 Ulm/Germany

phone: +49-731-500 65 801
fax: +49-731-500 65 822

Content responsible person in accordance to § 5 TMG and § 55 Abs. 2 RStV:
Prof. Dr. C. Buske (address as above)

Liability Note
Despite careful control we assume no liability for the content of external links. The content of the linked pages is the site operator’s responsibility.

Copyright
All images, logos and texts on these sites are property of “Comprehensive Cancer Center Ulm” and their partners. The reproduction and/or proliferation of the given content in any form require the written approval of “Comprehensive Cancer Center Ulm”.

Realisation

MJU.media Internetlösungen (www.mju-media.de)